A nimble Houston startup has raised a concise $28.4 million Series A to start a mid-stage trial.
The company, named March Biosciences, will enter Phase …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with breast cancer who are treated with the oral medication alpelisib.
Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director
Dive Brief: Cook Medical has signed a letter of intent to sell its reproductive health business to the private equity firm Astorg, the medtech company